Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions

Scandinavian Journal of Immunology

Volumn 46, Issue 2, 1997, Pages 195-203

  Hvas, J ^a,b   McLean, C ^c   Justesen, J ^a   Kannourakis, G ^d,e   Steinman, L ^a   Oksenberg, J R ^f   Bernard, C C A ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b LA TROBE UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; RANTES;

ARTICLE; DEMYELINATION; HUMAN; MEMORY CELL; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030827168     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-100.x     Document Type: Article

References (42)

1. Bernard CCA, Carnegie PR, Mackay IR. Immunoregulatory mechanisms in experimental autoimmune encephalomyelitis and multiple sclerosis. In: Adams CWM, Tourtellottee WW, Hallpike JF. eds. Multiple Sclerosis. London: Chapman & Hall, 1983;479-511.
2. Raine CS. Multiple sclerosis: a pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 1991;17:265-74.
3. Bernard CCA, Kerlero de Rosbo N. Multiple sclerosis: an autoimmune disease of multifactorial etiology. Curr Opin Immunol 1992;4:760-5.
4. Prineas JW. The neuropathology of multiple sclerosis. Handbook Clin Neurol 1985;3:213-56.
5. McFarlin DE, McFarland HF. Multiple sclerosis. N Engl J Med 1982;307:1183-8.
6. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis distribution of T cells, T cell subsets and Ia positive macrophages in lesions of different ages. J Neuroimmunol 1983;4:201-21.
7. Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 1988;140:2210-14.
8. Hafler DA, Duby AD, Lee SJ et al. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1988;167:1313-22.
9. Olsson T, Zhi WW, Hojeberg B et al. Autoreactive T lymphocytes secretion of interferon-γ. J Clin Invest 1990;86:981-5.
10. Selmaj K, Cross AH, Farooq M, Brosnan CF, Raine CS. Non-specific oligodendrocyte cytotoxicity mediated by soluble products of activated T cell lines. J Neuroimmunol 1991;35:261-4.
11. Lloyd AR, Oppenheim JJ, Kelvin DJ, Taub DD. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J Immunol 1996;156:932-8.
12. Schall TJ. Biology of the RANTES/Sis cytokine family. Cytokine 1991;3:165-83.
13. Kunkel SL, Strieter RM, Lindley IJD, Westwick J. Chemokines: new ligands, receptors and activities. Immunol Today 1995;16:559-61.
14. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-71.
15. Murphy WJ, Tian Z, Asai O. Chemokines and T lymphocyte activation. II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J Immunol 1996;156:2104-11.
16. Schall TJ, Jongstra J, Dyer BJ et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988; 141:1018-25.
17. Marfaing-Koka A, Devergne O, Gorgone G et al. Regulation of the production of the RANTES chemokine by endothelial cells. J Immunol 1995;154:1870-8.
18. Roth SJ, Carr MW, Springer TA. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein 10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol 1995;25:3482-8.
19. Ruthanaswumi P, Hachicha M, Sadick M et al. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J Biol Chem 1993;268:5834-9.
20. Devergne O, Marfaing-Koka A, Schall TJ et al. Production of the RANTES chemokine in delayed-type hypersensitivity reaction: involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-94.
21. Kondo T, Norvick AC, Toma H, Fairchild RL. Induction of chemokines gene expression during allogeneic skin graft rejection. Transplantation 1996;61:1750-7.
22. Godiska R, Chantry D, Dietsch GN, Gray PW. Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 1995;58:167-76.
23. Weiner HL, Ellison GW. A working protocol to be used as a guideline for trials in multiple sclerosis. Arch Neurol 1983; 40:704-70.
24. Chomczynski P, Sacchi N. Single-step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. Hvas J, Oksenberg JR, Fernando R, Steinman L, Bernard CCA. γδ T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J Neuroimmunol 1993;46:225-34.
26. Chou Q, Russell M, Birch DE et al. Prevention of pre-PCR mispriming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res 1992;20:1717-23.
27. Coghlan JP, Aldred P, Harolambitis J et al. Hybridisation histochemistry. Anal Biochem 1985;149:1-28.
28. Oksenberg JR, Stuart S, Begovich AB et al. Limited heterogeneity of rearranged T cell receptor Vα transcripts in brain of multiple sclerosis patients. Nature 1990;345:344-6.
29. Eoli MM, Ferrarine M, Dufour A et al. Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity. J Neurol 1993;240:79-84.
30. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.
31. Fahey TJ, Sherry B, Tracey KJ et al. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 1992;2:92-9.
32. Yla-Herttuala S, Lipton B, Rosenfeld M et al. Expression of MCP-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-7.
33. Villiger PM, Terkeitaub R, Lotz M. Monocyte chemoattractant Protein-1 (MCP-1) expression in human articular cartilage. J Clin Invest 1992;90:488-96.
34. Charlesworth EN, Hood AF, Soter NA et al. Cutaneous late-phase response to allergen. J Clin Invest 1989;83:1519-26.
35. + cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects. Clin Exp Immunol 1991;84:270-4.
36. Woodroofe MN, Loughlin AJ, Newcombe J, Cuzner ML. Detection of cytokine expression in the central nervous system in multiple sclerosis. Multiple Sclerosis 1996;2:5-6.
37. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8 and RANTES. Eur J Immunol 1995;25:751-6.
38. Correale J, Gilmore W, McMillan M et al. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 1995;154:2959-65.
39. Heeger P, Wolf G, Meyers C et al. Isolation and characterisation of cDNA from renal tubular epithelium encoding RANTES. Kidney Int 1992;41:220-4.
40. + T cells in response to MIP-1α and MIP-1β. Science 1993;260:355-8.
41. Pennica D, Nedwin GE, Hayflick JS et al. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:724-9.
42. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic b-Actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985;82:6133-7.